Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Recruiting
N/A
Interventional Study
Indolent Lymphomas
Lymphoma
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Follicular Lymphoma
Marginal Zone Lymphoma
Lymphoplasmacytic Lymphoma
Waldenstrom Macroglobulinemia
Cutaneous T Cell Lymphoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 40 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This health services study will assess a multidisciplinary intervention program directed at fatigue mitigation among patients diagnosed with indolent lymphomas. Specifically, 30 subjects with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 10 subjects with Follicular Lymphoma (FL), marginal zone lymphoma (MZL), lymphoplasmacytic lymphoma (LPL), Waldenström's Macroglobulinemia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria:
* Written informed consent was obtained to participate in the study and HIPAA authorization for the release of personal health information.
* Subjects are willing and able …
Contacts